AB-FUBINACA: Difference between revisions
>David Hedlund ===Dangerous interactions=== {{DangerousInteractions/Intro}} {{DangerousInteractions/Cannabis}} |
>Tracer m Changed chemical class |
||
Line 9: | Line 9: | ||
Unlike [[cannabis]], the chronic abuse of [[synthetic cannabinoids]] has been [[Synthetic_cannabinoid#Deaths|associated with multiple deaths]] and [[Synthetic cannabinoid#Harm potential|more dangerous side effects and higher toxicity]]. It is strongly discouraged to take this substance for extended periods of time or in high doses. | Unlike [[cannabis]], the chronic abuse of [[synthetic cannabinoids]] has been [[Synthetic_cannabinoid#Deaths|associated with multiple deaths]] and [[Synthetic cannabinoid#Harm potential|more dangerous side effects and higher toxicity]]. It is strongly discouraged to take this substance for extended periods of time or in high doses. | ||
==Chemistry== | ==Chemistry== | ||
AB-FUBINACA, or N-[(1S)-1-(Aminocarbonyl)-2-methylpropyl]-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide, is a synthetic [[Chemical class:: | AB-FUBINACA, or N-[(1S)-1-(Aminocarbonyl)-2-methylpropyl]-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide, is a synthetic [[Chemical class::indazolecarboxamide]] drug as it contains a substituted indazole core. A 4-substituted fluorophenyl group is bound to this indazole core through a methyl group at R<sub>1</sub> of the indazole. This indazole is substituted at R<sub>3</sub> with a carboxamide group. The terminal amine of this carboxamide is bonded to a substituted propyl chain with an aminocarbonyl group at R<sub>1</sub> and a methyl group at R<sub>2</sub>. | ||
==Pharmacology== | ==Pharmacology== |